BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 21354304)

  • 1. UVA1 radiation inhibits calcineurin through oxidative damage mediated by photosensitization.
    Musson RE; Hensbergen PJ; Westphal AH; Temmink WP; Deelder AM; van Pelt J; Mullenders LH; Smit NP
    Free Radic Biol Med; 2011 May; 50(10):1392-9. PubMed ID: 21354304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of arsenite and UVA-1 radiation on calcineurin signaling.
    Musson RE; Mullenders LH; Smit NP
    Mutat Res; 2012 Jul; 735(1-2):32-8. PubMed ID: 22564430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II type 1 receptor-associated protein prevents vascular smooth muscle cell senescence via inactivation of calcineurin/nuclear factor of activated T cells pathway.
    Min LJ; Mogi M; Tamura K; Iwanami J; Sakata A; Fujita T; Tsukuda K; Jing F; Iwai M; Horiuchi M
    J Mol Cell Cardiol; 2009 Dec; 47(6):798-809. PubMed ID: 19769983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low UVA doses activate the transcription factor NFAT in human fibroblasts by a calcium-calcineurin pathway.
    Mazière C; Morlière P; Louandre C; Conte MA; Gomilla C; Santus R; Antonicelli F; Hornebeck W; Mazière JC
    Free Radic Biol Med; 2005 Dec; 39(12):1629-37. PubMed ID: 16298688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia.
    Medyouf H; Alcalde H; Berthier C; Guillemin MC; dos Santos NR; Janin A; Decaudin D; de Thé H; Ghysdael J
    Nat Med; 2007 Jun; 13(6):736-41. PubMed ID: 17515895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of calcineurin by quercetin in vitro and in Jurkat cells.
    Wang H; Zhou CL; Lei H; Wei Q
    J Biochem; 2010 Feb; 147(2):185-90. PubMed ID: 19880376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superoxide targets calcineurin signaling in vascular endothelium.
    Namgaladze D; Shcherbyna I; Kienhöfer J; Hofer HW; Ullrich V
    Biochem Biophys Res Commun; 2005 Sep; 334(4):1061-7. PubMed ID: 16038879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas ligand induction in human NK cells is regulated by redox through a calcineurin-nuclear factors of activated T cell-dependent pathway.
    Furuke K; Shiraishi M; Mostowski HS; Bloom ET
    J Immunol; 1999 Feb; 162(4):1988-93. PubMed ID: 9973469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcineurin mutants render T lymphocytes resistant to cyclosporin A.
    Zhu D; Cardenas ME; Heitman J
    Mol Pharmacol; 1996 Sep; 50(3):506-11. PubMed ID: 8794888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of nuclear translocation of calcineurin suppresses T-cell activation and prevents acute rejection of donor hearts.
    Panther F; Strasen J; Czolbe M; Lazariotou M; Burkard N; Williams T; Lange V; Otto C; Ritter O
    Transplantation; 2011 Mar; 91(6):597-604. PubMed ID: 21228752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin A promotes growth and invasiveness in vitro of human first-trimester trophoblast cells via MAPK3/MAPK1-mediated AP1 and Ca2+/calcineurin/NFAT signaling pathways.
    Du MR; Zhou WH; Dong L; Zhu XY; He YY; Yang JY; Li DJ
    Biol Reprod; 2008 Jun; 78(6):1102-10. PubMed ID: 18322274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin A, but not everolimus, inhibits DNA repair mediated by calcineurin: implications for tumorigenesis under immunosuppression.
    Thoms KM; Kuschal C; Oetjen E; Mori T; Kobayashi N; Laspe P; Boeckmann L; Schön MP; Emmert S
    Exp Dermatol; 2011 Mar; 20(3):232-6. PubMed ID: 21323745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory mechanisms of calcineurin phosphatase activity.
    Musson RE; Smit NP
    Curr Med Chem; 2011; 18(2):301-15. PubMed ID: 21110798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Good fungi gone bad: the corruption of calcineurin.
    Fox DS; Heitman J
    Bioessays; 2002 Oct; 24(10):894-903. PubMed ID: 12325122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive agents in organ transplantation: past, present, and future.
    Hong JC; Kahan BD
    Semin Nephrol; 2000 Mar; 20(2):108-25. PubMed ID: 10746855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multiple actions of tacrolimus and cyclosporin A as specific inhibitors of calcineurin].
    Tamura K
    Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1118-30. PubMed ID: 9655970
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects and mechanisms of tacrolimus on development of murine Th17 cells.
    Zhang XJ; Kang YD; Xiao L; Li RD; Ding GS; Wang ZX; Fu ZR
    Transplant Proc; 2010 Nov; 42(9):3779-83. PubMed ID: 21094856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcineurin stimulates the expression of inflammatory factors in RAW 264.7 cells by interacting with proteasome subunit alpha type 6.
    Zhang W; Wei Q
    Biochem Biophys Res Commun; 2011 Apr; 407(4):668-73. PubMed ID: 21420386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methionine oxidation in the calmodulin-binding domain of calcineurin disrupts calmodulin binding and calcineurin activation.
    Carruthers NJ; Stemmer PM
    Biochemistry; 2008 Mar; 47(10):3085-95. PubMed ID: 18275158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcineurin inhibitors and the generalization of the presenting protein strategy.
    Vogel KW; Briesewitz R; Wandless TJ; Crabtree GR
    Adv Protein Chem; 2001; 56():253-91. PubMed ID: 11329856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.